Status:
COMPLETED
Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Medulloblastoma, Childhood
Cerebral Primitive Neuroectodermal Tumor
Eligibility:
All Genders
Up to 21 years
Brief Summary
The Register is based on the study HIT 2000 that recruited patients until 31.12.2011. All german patients with intracranial medulloblastoma, CNS-PNET, ependymoma can be included in the register. Objec...
Detailed Description
The Register is based on the study HIT 2000 that recruited patients until 31.12.2011. All german patients with intracranial medulloblastoma, CNS-PNET, ependymoma can be included in the register. Objec...
Eligibility Criteria
Inclusion
- age at diagnosis 0-21 years
- histologically proven medulloblastoma, CNS-PNET (incl. pineoblastoma, ependymoblastoma, CNS-neuroblastoma), or ependymoma (WHO II/ III)
Exclusion
- none
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT02238899
Start Date
January 1 2011
End Date
December 1 2014
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Hamburg, Germany, 20246